Delivery Order SPE2DB20D1100-SPE2DB24FA8Q2
Award Date
3/21/24
Potential Completion Date
3/22/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,408.62 firm-fixed-price delivery order is for the supply of the pharmaceutical product GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.28 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The award has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order valued at $2,426.43 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a period of performance through October 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has a ceiling value of $6,050.03 and is a Delivery Order under a Firm Fixed Price contract type. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be delivering the specified medical commodity to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,200.94, is a delivery order for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML and has an ultimate completion date of April 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the parent company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a Firm Fixed Price Delivery Order for $1,769.04 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GVOKE PFS 1-PK 1 MG/0.2 ML SYR 0.2ML, a medical product, to support military healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This is a $14,426.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of February 7, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,263.48 for the provision of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 2, 2024, with a completion date of May 3, 2024. The contract type is Firm Fixed Price. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,547.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a medical product, with a completion date of March 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,892.43 for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. The contract has an ultimate completion date of June 11, 2024 and is a Firm Fixed Price arrangement. The award is issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies....